# Study of Neuroimaging Biomarkers of Social Cognition Deficits in Adolescents (Age 13-17) With Autism Spectrum Disorder and Effects of Gabapentin

> **NCT03589898** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Massachusetts, Worcester** · enrollment: 19 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Gabapentin

## Key facts

- **NCT ID:** NCT03589898
- **Lead sponsor:** University of Massachusetts, Worcester
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-14
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2022-11-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03589898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03589898, "Study of Neuroimaging Biomarkers of Social Cognition Deficits in Adolescents (Age 13-17) With Autism Spectrum Disorder and Effects of Gabapentin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03589898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*